Home > Boards > US Listed > Miscellaneous > Diffusion Pharmaceuticals Inc. (DFFN)

Noiceeeee!!!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
maximumgriff Member Profile
 
Followed By 67
Posts 5,099
Boards Moderated 0
Alias Born 03/07/17
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/18/2020 4:53:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/18/2020 4:53:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/17/2020 4:38:22 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2020 12:19:42 PM
Diffusion Pharmaceuticals Files Clinical Trial Application for European Phase 1a/1b Study of TSC in COVID-19 Patients GlobeNewswire Inc. - 6/11/2020 8:00:10 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 6/11/2020 6:00:53 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 6/8/2020 4:49:08 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 6/3/2020 5:26:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2020 4:41:48 PM
Diffusion Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement GlobeNewswire Inc. - 6/1/2020 8:00:10 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 5/29/2020 5:23:11 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 5/27/2020 4:58:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2020 4:46:11 PM
Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program GlobeNewswire Inc. - 5/26/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2020 5:28:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2020 5:23:48 PM
Diffusion Pharmaceuticals Inc. Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 5/20/2020 1:00:10 PM
Diffusion Pharmaceuticals Expands Clinical Trial Program of TSC for the Treatment of COVID-19 Patients to Include the Romania... GlobeNewswire Inc. - 5/20/2020 8:00:10 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/19/2020 5:30:26 PM
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire Inc. - 5/18/2020 9:05:33 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 5/15/2020 4:33:57 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/13/2020 4:53:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/11/2020 4:59:49 PM
Diffusion Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update GlobeNewswire Inc. - 5/11/2020 4:11:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/11/2020 4:03:40 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist